These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33610748)

  • 21. Development of benzimidazole-based compounds as novel capsid assembly modulators for the treatment of HBV infection.
    Du K; Wang X; Bai Y; Zhang X; Xue J; Li S; Xie Y; Sang Z; Tang Y; Wang X
    Eur J Med Chem; 2024 May; 271():116402. PubMed ID: 38636128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new series of HAPs as anti-HBV agents targeting at capsid assembly.
    Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro.
    Corcuera A; Stolle K; Hillmer S; Seitz S; Lee JY; Bartenschlager R; Birkmann A; Urban A
    Antiviral Res; 2018 Oct; 158():135-142. PubMed ID: 30031759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and Evaluation of N-Phenyl-3-sulfamoyl-benzamide Derivatives as Capsid Assembly Modulators Inhibiting Hepatitis B Virus (HBV).
    Vandyck K; Rombouts G; Stoops B; Tahri A; Vos A; Verschueren W; Wu Y; Yang J; Hou F; Huang B; Vergauwen K; Dehertogh P; Berke JM; Raboisson P
    J Med Chem; 2018 Jul; 61(14):6247-6260. PubMed ID: 29906396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).
    Ren Q; Liu X; Luo Z; Li J; Wang C; Goldmann S; Zhang J; Zhang Y
    Bioorg Med Chem; 2017 Feb; 25(3):1042-1056. PubMed ID: 28082068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors.
    Ma Y; Zhao S; Ren Y; Cherukupalli S; Li Q; Woodson ME; Bradley DP; Tavis JE; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 225():113780. PubMed ID: 34438123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Plasma Protein Binding on the Anti-Hepatitis B Virus Activity and Pharmacokinetic Properties of NVR 3-778.
    Helsen N; Vervoort T; Vandenbossche J; Lenz O; Monshouwer M; Pauwels F; Snoeys J
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Core Protein-Directed Antivirals and Importin β Can Synergistically Disrupt Hepatitis B Virus Capsids.
    Kim C; Barnes LF; Schlicksup CJ; Patterson AJ; Bothner B; Jarrold MF; Wang CJ; Zlotnick A
    J Virol; 2022 Jan; 96(2):e0139521. PubMed ID: 34705562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.
    Wu S; Zhao Q; Zhang P; Kulp J; Hu L; Hwang N; Zhang J; Block TM; Xu X; Du Y; Chang J; Guo JT
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28566379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.
    Senaweera S; Du H; Zhang H; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector.
    Sari O; Boucle S; Cox BD; Ozturk T; Russell OO; Bassit L; Amblard F; Schinazi RF
    Eur J Med Chem; 2017 Sep; 138():407-421. PubMed ID: 28688280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B Virus Capsids Have Diverse Structural Responses to Small-Molecule Ligands Bound to the Heteroaryldihydropyrimidine Pocket.
    Venkatakrishnan B; Katen SP; Francis S; Chirapu S; Finn MG; Zlotnick A
    J Virol; 2016 Apr; 90(8):3994-4004. PubMed ID: 26842475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of small synthetic molecules targeting HBV capsid assembly.
    Liu N; Zhao F; Zhan P; Liu X
    Med Chem; 2015; 11(8):710-6. PubMed ID: 25985859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of N-sulfonylpiperidine-3-carboxamide derivatives as capsid assembly modulators inhibiting HBV in vitro and in HBV-transgenic mice.
    Yin J; Feng Z; Li Z; Hu J; Hu Y; Cai X; Zhou H; Wang K; Tang N; Huang A; Huang L
    Eur J Med Chem; 2023 Mar; 249():115141. PubMed ID: 36709646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Di-fluoro azepane HBV capsid assembly modulators.
    DeRatt LG; Stoops B; Shaffer P; Lam AM; Espiritu C; Vogel R; Lau V; Flores OA; Kuduk SD
    Bioorg Med Chem Lett; 2023 Aug; 92():129350. PubMed ID: 37247697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bay41-4109-induced aberrant polymers of hepatitis b capsid proteins are removed via STUB1-promoted p62-mediated macroautophagy.
    Lin J; Yin L; Xu XZ; Sun HC; Huang ZH; Ni XY; Chen Y; Lin X
    PLoS Pathog; 2022 Jan; 18(1):e1010204. PubMed ID: 35030230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors.
    Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H
    Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly.
    Xi J; Gu Z; Sun C; Chen Z; Zhang T; Chen R; Liu T; Liao H; Zou J; Yang D; Xu Q; Wang J; Wei G; Cheng Z; Lu F; Chen X
    Antiviral Res; 2023 Oct; 218():105715. PubMed ID: 37683938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel non-HAP class A HBV capsid assembly modulators have distinct
    Vanrusselt H; Kum DB; Taverniti V; Liu C; Acosta Sanchez A; Corthout N; Munck S; Baumert TF; Beigelman L; Blatt LM; Symons JA; Deval J; Raboisson P; Verrier ER; Jekle A; Vendeville S; Debing Y
    J Virol; 2023 Oct; 97(10):e0072223. PubMed ID: 37754761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.